Hemoglobinuria: Causes, Tests, Care

Red or cola-colored urine can be alarming. Hemoglobinuria is one reason it happens—and it often gets mistaken for blood. Learn the signs, key tests, and what to do next.

What Is Hemoglobinuria?

Hemoglobinuria is the presence of free hemoglobin in urine. It usually occurs when red blood cells are destroyed within the bloodstream (intravascular hemolysis), releasing hemoglobin that gets filtered by the kidneys. While it may look like blood in the urine, it is not the same as having intact red blood cells pass into urine. Understanding the difference helps clinicians identify the underlying cause and treat you faster.
For deeper background on mechanisms and clinical contexts, see this concise overview: ScienceDirect Topics on hemoglobinuria.

Hemoglobinuria vs. Hematuria: Why It Matters

Hematuria means whole red blood cells are present in urine, often from kidney, ureter, bladder, or urethral sources. Hemoglobinuria, by contrast, means the red cells have already broken open in the bloodstream and hemoglobin has leaked out and is being cleared by the kidneys. Urinalysis can help distinguish the two:

Dipstick “blood” positive, no RBCs on microscopy: This pattern suggests hemoglobinuria (or myoglobinuria) rather than hematuria.
Dipstick “blood” positive with RBCs on microscopy: More consistent with hematuria (e.g., stones, infection, tumor, trauma).
Plasma color matters: Reddish-brown plasma suggests hemoglobinemia; clear plasma with brown urine suggests myoglobinuria.

A clinical review that explains common pitfalls in interpretation is available here: Review on distinguishing hemoglobinuria from hematuria.

Common Causes in Adults and Children

Multiple conditions can lead to intravascular hemolysis and subsequent hemoglobinuria:

Paroxysmal nocturnal hemoglobinuria (PNH): An acquired bone marrow disorder with complement-mediated hemolysis and risk for blood clots.
Transfusion reactions: Acute hemolysis after incompatible blood transfusion is a medical emergency.
Mechanical hemolysis: Shear stress from prosthetic heart valves, LVADs, or severe marches/running (“march hemoglobinuria”).
Infections and toxins: Severe malaria, clostridial sepsis, and certain toxins can rupture red blood cells.
Drug or oxidant stress: In susceptible patients (e.g., G6PD deficiency), certain medications or fava beans can trigger hemolysis.
Microangiopathic hemolytic anemia: Conditions like TTP/HUS and DIC fragment red cells and may cause hemoglobinuria.
Thermal injury: Extensive burns may lead to intravascular hemolysis.
Severe autoimmune hemolysis: Some forms of autoimmune hemolytic anemia can be intravascular.

Symptoms and Red Flags

Not everyone with hemoglobinuria has obvious symptoms beyond dark urine. Pay attention to:

Urine color changes: Reddish, cola, or brown urine that persists.
Anemia symptoms: Fatigue, shortness of breath, palpitations, lightheadedness.
Jaundice: Yellowing of the skin or eyes from increased bilirubin.
Back or abdominal pain: May accompany brisk hemolysis.
Clotting symptoms (PNH risk): Leg swelling or pain, chest pain, sudden shortness of breath, or neurological changes—call 911 for severe symptoms.
Signs of infection or transfusion reaction: Fever, chills, dark urine soon after transfusion—seek urgent care.

How Clinicians Diagnose It

Evaluation typically proceeds in steps to confirm hemoglobinuria, assess severity, and identify the cause:

Urinalysis with microscopy: A positive blood dipstick without red cells points toward hemoglobinuria or myoglobinuria.
Plasma appearance: Pink or red plasma supports hemoglobinemia; clear plasma with brown urine leans toward myoglobinuria.
Hemolysis labs: High LDH and indirect bilirubin, low haptoglobin, and elevated reticulocyte count support intravascular hemolysis.
Renal function: Creatinine and urinalysis help evaluate kidney involvement.
Hemoglobinuria-specific tests: Some labs measure plasma free hemoglobin; others rely on broader hemolysis panels.
PNH testing: High-sensitivity flow cytometry for GPI-deficient clones on white and red blood cells is the standard approach. See: Cleveland Clinic overview of PNH and Medscape PNH overview.
Other causes: Depending on history, clinicians may order tests for infection, autoimmune disease, or mechanical hemolysis.

Focused Look: Paroxysmal Nocturnal Hemoglobinuria (PNH)

PNH is an acquired stem-cell disorder in which affected blood cells lack protective proteins that normally shield them from the body’s complement system. The result can be chronic or episodic intravascular hemolysis, leading to dark urine—often noticed in the morning—fatigue, abdominal pain, erectile dysfunction, and a high risk of thrombosis in unusual locations (e.g., hepatic or cerebral veins). Bone marrow failure can coexist, causing low blood counts.
Modern care for PNH includes complement inhibitors (e.g., eculizumab, ravulizumab) that dramatically reduce hemolysis and thrombosis risk. Patients typically need vaccination and sometimes prophylactic antibiotics because complement inhibition raises susceptibility to certain infections, especially meningococcal disease. Treatment plans are individualized, and hematology referral is essential.

Treatment Principles for Hemoglobinuria

The approach depends on the underlying cause and severity:

Stabilize first: Severe anemia, shock, suspected transfusion reactions, or signs of organ damage require emergency care.
Hydration and kidney protection: Intravenous fluids and, at times, urine alkalinization may be used to limit tubular injury from pigment.
Address the trigger: Stop offending drugs, treat infections, adjust mechanical devices, or manage autoimmune disease.
Targeted therapy: For PNH, complement inhibitors; for microangiopathy, disease-specific protocols (e.g., plasma exchange for TTP).
Nutritional support: Iron and folate may be needed with chronic hemolysis.
Monitoring: Serial labs to track hemolysis markers, kidney function, and response to therapy.

Costs of Testing and Care in the U.S.

Prices vary by location, insurance status, and where tests are performed. The cash prices below are illustrative, pulled from common direct-access lab providers and published self-pay menus where available. Always confirm current pricing with the provider before purchasing or scheduling, and note that specialized testing (e.g., PNH flow cytometry) typically requires a clinician’s order and may cost more.

Provider & Location	Test	Sample Cash Price (USD)
Walk-In Lab (Houston, TX)	Urinalysis, Complete (UA)	$29
Any Lab Test Now (Phoenix, AZ)	Urinalysis with Microscopic	$49
Ulta Lab Tests (Los Angeles, CA)	Haptoglobin	$39
Health Testing Centers (Miami, FL)	Lactate Dehydrogenase (LDH)	$44
Request A Test (Columbus, OH)	Reticulocyte Count	$59
Quest Diagnostics PSC (Dallas, TX)	Bilirubin, Total & Direct	$39
Labcorp PSC (Orlando, FL)	CBC with Differential	$36
Discounted Labs (San Antonio, TX)	Creatinine (Serum)	$28
Any Lab Test Now (Atlanta, GA)	Urine Myoglobin (qualitative)	$69
Walk-In Lab (Chicago, IL)	Iron Panel (supportive test)	$38

Note: Prices are approximate and may change. Hospital-based testing, comprehensive hemolysis panels, and specialized assays (e.g., PNH flow cytometry) can cost significantly more and often require physician ordering. Medication costs also vary widely; complement inhibitors for PNH are high-cost therapies typically coordinated through specialty pharmacies and insurance case management.

Prevention and Practical Tips

While not all causes are preventable, you can reduce risks and act early:

Hydrate during endurance activity: Adequate fluids and rest days can lower risk of exercise-related pigmenturia.
Share your medication list: Tell your clinician about all drugs and supplements, especially if you have G6PD deficiency or a history of hemolysis.
Use the same lab when possible: Consistent testing helps track trends in LDH, bilirubin, and reticulocytes.
Know urgent symptoms: Sudden dark urine with fever, chest pain, trouble breathing, or confusion warrants immediate care.
Vaccinations for PNH on therapy: Stay current with meningococcal and other recommended vaccines if receiving complement inhibitors.

Questions to Ask Your Clinician

What is the likely cause of the urine color change? Do my labs suggest hemoglobinuria, hematuria, or myoglobinuria?
Which tests do I need now? Will I need repeat labs to monitor hemolysis or kidney function?
If PNH is suspected, how is flow cytometry arranged and how long do results take?
What are my treatment options, and how urgent is therapy?
How will insurance handle testing and medications? Are there assistance programs if I’m uninsured or underinsured?